Bhubaneswar (Odisha) [India], July 28 (ANI): The human trial of India's first indigenous vaccine candidate 'Covaxin' began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Monday.

Covaxin, the vaccine developed by Bharat Biotech, has been administered to several persons, who volunteered to be part of the trial, said Dr E Venkat Rao, Principal Investigator of the trial process.

Also Read | Lockdown Didn't Slow COVID-19 Spread in Thiruvananthapuram, People Should Be Allowed to Resume Normal Lives, Says Shashi Tharoor.

The vaccination was conducted after the volunteers underwent a rigorous screening procedure.

"There was a lot of enthusiasm among people who offered themselves to be volunteers for the trial," he said.

Also Read | Kolhapur District Administration Registers FIR Against Six COVID-19 Patients for Playing Football Without Face Masks Inside Isolation Centre: Live News Breaking And Coronavirus Updates on July 27, 2020.

The Indian Council for Medical Research (ICMR) which is collaborating with Bharat Biotech for the development of the vaccine, has chosen 12 medical institutes across the country. IMS and SUM Hospital is the only such institute in Odisha to be chosen for the purpose.

Those interested to volunteer for the project may contact the institute by registering online at ptctu.soa.ac.in under the section register for clinical trials.

However, volunteers are required to be disease-free and can screen themselves through a simple questionnaire available at the same website, a statement from SUM hospital said. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)